Table 12.10b

Adjusted Patient Survival, Living Donor Lung Transplants

Survival at 3 Months, 1 Year, 3 Years, and 5 Years

		3 Months			1 Year			3 Years			5 Years
		N	%	Std. Err.	N	%	Std. Err.	N	%	Std. Err.	N	%	Std. Err.
Total	All	35	89.3%	5.3%	35	72.6%	8.2%	50	41.4%	6.9%	41	49.5%	9.2%
Primary Diagnosis	Cystic Fibrosis	29	87.0%	6.3%	29	66.2%	9.5%	44	40.1%	7.3%	35	51.7%	10.2%
	Idiopathic Pulmonary Fibrosis	2	+	+	2	+	+	0	-	-	3	0.0%	0.0%
	Primary Pulmonary Hypertension	1	+	+	1	+	+	0	-	-	3	53.0%	29.3%
	Congenital Disease	0	-	-	0	-	-	2	+	+	0	-	-
	Other	3	+	+	3	+	+	4	24.5%	15.9%	0	-	-

Source: OPTN/SRTR Data as of August 1, 2003.

(+) = Values not determined due to insufficient follow-up.

(-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during 2000-2001 for 3 month and 1 year; 1998-1999 for 3 year; and 1996-1997 for 5 year survival.

Patient survival follows patients from first transplant of this type until death.

Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on lung and heart-lung transplants.

Multi-organ transplants are excluded.

Survival rates are adjusted to the characteristics of the 3 month and 1 year cohort. See Technical Notes for details.